Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$172.6M
3 rounds on record
Latest round
$56M
Venture round · Jan 2024 · 2 yr ago
Backers
1
venBio Partners
The money's age
Long since its last round
32 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jan 2024 $56M — SEC Form D
Venture round Aug 2021 $116.6M — SEC Form D
Debt Financing Dec 2019 $175k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Attralus, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Benson FongExecutive OfficerSEC Form D
Greg BellExecutive OfficerSEC Form D
Spencer GuthrieExecutive OfficerSEC Form D
Mark TimneyExecutive Officer, DirectorSEC Form D
Jonathan WallExecutive OfficerSEC Form D
Mehdi KhodadadExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Immunai13 roles
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
A new path forpatients with Chronic Kidney Disease. At Pathalys Pharma, Inc. we are committed to improving the lives of patients through…
Cisterna BiologicsFounded 2025 • 11-50 employees
High-purity RNA for research and development. Cisterna Biologics offers custom RNA synthesis, including mRNA, with fast turnaround and…
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key…
LabGenius51-200 employees
LabGenius Therapeutics is pioneering a closed-loop platform that combines AI, robotic automation, and synthetic biology to accelerate the…
Opna BioFounded 2020 • 51-200 employees
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics. The…

Overview

Attralus is focused on advancing new solutions for amyloidosis therapy. The team has deep experience in Amyloid research and therapeutic development.

People

Benson Fong
Executive Officer
Greg Bell
Executive Officer
Spencer Guthrie
Executive Officer
Mark Timney
Executive Officer, Director
Jonathan Wall
Executive Officer
Mehdi Khodadad
Executive Officer
Glen Firestone
Executive Officer
Gregory Bell
Executive Officer
James Testa
Executive Officer
Scientific Advisory
Directors
Rahul Kakkar
Director
Jake Bauer
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
South San Francisco United States
HQ
Naples United States
Regional office
Follow
365 Fifth Ave South, Ste 208, Naples, FL 34102
company site

Financials

Total raised
$172.8M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $56M Details
Venture - Series Unknown 2021 $116.6M Details
Debt Financing 2019 $175k Details